These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7023899)

  • 1. Trimethoprim: clinical use and pharmacokinetics.
    Friesen WT; Hekster YA; Vree TB
    Drug Intell Clin Pharm; 1981 May; 15(5):325-30. PubMed ID: 7023899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of trimethoprim with sulfonamides other than sulfamethoxazole.
    Bernstein LS
    Rev Infect Dis; 1982; 4(2):411-8. PubMed ID: 7051239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethoprim/sulfonamide combinations in the horse: a review.
    Van Duijkeren E; Vulto AG; Van Miert AS
    J Vet Pharmacol Ther; 1994 Feb; 17(1):64-73. PubMed ID: 8196097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of the new sulfamethopyrazine-trimethoprim combination (kelfiprim) in renal insufficiency.
    Cantaluppi A; Graziani G; Ponticelli C; Grasso S; Meinardi G; Piaia F; Tamassia V
    Eur J Clin Pharmacol; 1984; 27(3):345-8. PubMed ID: 6510463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim/sulfonamide: rational combination therapy.
    Hitchings GH; Singleton SW
    Compr Ther; 1976 May; 2(5):55-63. PubMed ID: 776520
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of trimethoprim alone or in combination with drugs other than sulfonamides.
    Brumfitt W; Hamilton-Miller JM
    Rev Infect Dis; 1982; 4(2):402-10. PubMed ID: 7051238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
    Quintiliani R; Levitz RE; Nightingale CH
    Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of the sulfonamide component for the clinical efficacy of trimethoprim-sulfonamide combinations.
    Burman LG
    Scand J Infect Dis; 1986; 18(2):89-99. PubMed ID: 3518051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on synergistic behaviour and pharmacokinetics of the combination sulfonamide/trimethoprim. IV. A comparative study on potentiating the trimethoprim effect by various sulfonamides and critical observations on its dosing (author's transl)].
    Seydel JK; Wempe E
    Arzneimittelforschung; 1977; 27(8):1521-32. PubMed ID: 334187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole in treatment of severe infections.
    Salter AJ
    Rev Infect Dis; 1982; 4(2):338-50. PubMed ID: 7051234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK; Ronald AR; Boutros P; Lank B
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of trimethoprim/sulfadiazine in neonatal calves: influence of synovitis.
    Shoaf SE; Schwark WS; Guard CL; Schwartsman RV
    J Vet Pharmacol Ther; 1986 Dec; 9(4):446-54. PubMed ID: 3806787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence.
    Vouloumanou EK; Karageorgopoulos DE; Rafailidis PI; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2011 Sep; 38(3):197-216. PubMed ID: 21741802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole: A reappraisal.
    O'Grady F
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):5-7. PubMed ID: 1079470
    [No Abstract]   [Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole and trimethoprim alone in the prophylaxis of childhood urinary tract infection.
    Smellie JM; Grüneberg RN; Normand IC; Bantock HM
    Rev Infect Dis; 1982; 4(2):461-6. PubMed ID: 6981164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to trimethoprim-sulfamethoxazole, with particular reference to long-term therapy.
    Bernstein LS
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):96-8. PubMed ID: 124200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of trimethoprim-sulfamethoxazole in pediatric infections: relative merits of intravenous administration.
    Overturf GD
    Rev Infect Dis; 1987; 9 Suppl 2():S168-76. PubMed ID: 3554455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.
    Aarbakke J; Opshaug O; Digranes A; Høylandskjaer A; Fluge G; Fellner H
    Eur J Clin Pharmacol; 1983; 24(2):267-71. PubMed ID: 6840178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.